Search Results - (Author, Cooperation:R. I. Fisher)
-
1Latest Papers from Table of Contents or Articles in PressV. N. Ngo ; R. M. Young ; R. Schmitz ; S. Jhavar ; W. Xiao ; K. H. Lim ; H. Kohlhammer ; W. Xu ; Y. Yang ; H. Zhao ; A. L. Shaffer ; P. Romesser ; G. Wright ; J. Powell ; A. Rosenwald ; H. K. Muller-Hermelink ; G. Ott ; R. D. Gascoyne ; J. M. Connors ; L. M. Rimsza ; E. Campo ; E. S. Jaffe ; J. Delabie ; E. B. Smeland ; R. I. Fisher ; R. M. Braziel ; R. R. Tubbs ; J. R. Cook ; D. D. Weisenburger ; W. C. Chan ; L. M. Staudt
Nature Publishing Group (NPG)
Published 2010Staff ViewPublication Date: 2010-12-24Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Amino Acid Sequence ; Amino Acid Substitution ; Burkitt Lymphoma/genetics ; Cell Line, Tumor ; Cell Survival ; Cytokines/metabolism/secretion ; High-Throughput Nucleotide Sequencing ; Humans ; Hydrophobic and Hydrophilic Interactions ; Interleukin-1 Receptor-Associated Kinases/biosynthesis/genetics/metabolism ; Janus Kinases/metabolism ; Lymphoma, B-Cell, Marginal Zone/genetics ; Lymphoma, Large B-Cell, Diffuse/classification/*genetics/*pathology ; Molecular Sequence Data ; Mutant Proteins/chemistry/genetics/metabolism ; Mutation/*genetics ; Myeloid Differentiation Factor 88/chemistry/*genetics/*metabolism ; NF-kappa B/metabolism ; Oncogenes/*genetics ; Phosphorylation ; Protein Structure, Tertiary ; RNA Interference ; Receptors, Interleukin-1/metabolism ; STAT3 Transcription Factor/metabolism ; Sequence Analysis, RNA ; Signal Transduction ; Toll-Like Receptors/metabolismPublished by: -
2Latest Papers from Table of Contents or Articles in PressR. Schmitz ; R. M. Young ; M. Ceribelli ; S. Jhavar ; W. Xiao ; M. Zhang ; G. Wright ; A. L. Shaffer ; D. J. Hodson ; E. Buras ; X. Liu ; J. Powell ; Y. Yang ; W. Xu ; H. Zhao ; H. Kohlhammer ; A. Rosenwald ; P. Kluin ; H. K. Muller-Hermelink ; G. Ott ; R. D. Gascoyne ; J. M. Connors ; L. M. Rimsza ; E. Campo ; E. S. Jaffe ; J. Delabie ; E. B. Smeland ; M. D. Ogwang ; S. J. Reynolds ; R. I. Fisher ; R. M. Braziel ; R. R. Tubbs ; J. R. Cook ; D. D. Weisenburger ; W. C. Chan ; S. Pittaluga ; W. Wilson ; T. A. Waldmann ; M. Rowe ; S. M. Mbulaiteye ; A. B. Rickinson ; L. M. Staudt
Nature Publishing Group (NPG)
Published 2012Staff ViewPublication Date: 2012-08-14Publisher: Nature Publishing Group (NPG)Print ISSN: 0028-0836Electronic ISSN: 1476-4687Topics: BiologyChemistry and PharmacologyMedicineNatural Sciences in GeneralPhysicsKeywords: Basic Helix-Loop-Helix Transcription Factors/antagonists & ; inhibitors/genetics/metabolism ; Burkitt Lymphoma/*drug therapy/*genetics/metabolism/pathology ; Cell Cycle ; Cyclin D3/genetics/metabolism ; Cyclin-Dependent Kinase 6/metabolism ; Genes, myc/genetics ; *Genomics ; High-Throughput Nucleotide Sequencing ; Humans ; Inhibitor of Differentiation Proteins/genetics/metabolism ; *Molecular Targeted Therapy ; Neoplasm Proteins/genetics/metabolism ; Phosphatidylinositol 3-Kinases/metabolism ; RNA Interference ; Receptors, Antigen, B-Cell/metabolism ; Signal TransductionPublished by: -
3Latest Papers from Table of Contents or Articles in PressNature of lattice distortions in the cubic double perovskite ${\mathrm{Ba}}_{2}{\mathrm{NaOsO}}_{6}$W. Liu, R. Cong, A. P. Reyes, I. R. Fisher, and V. F. Mitrović
American Physical Society (APS)
Published 2018Staff ViewPublication Date: 2018-06-15Publisher: American Physical Society (APS)Print ISSN: 1098-0121Electronic ISSN: 1095-3795Topics: PhysicsKeywords: Structure, structural phase transitions, mechanical properties, defectsPublished by: -
4Latest Papers from Table of Contents or Articles in PressCompeting soft phonon modes at the charge-density-wave transitions in $\mathrm{DyT}{\mathrm{e}}_{3}$M. Maschek, D. A. Zocco, S. Rosenkranz, R. Heid, A. H. Said, A. Alatas, P. Walmsley, I. R. Fisher, and F. Weber
American Physical Society (APS)
Published 2018Staff ViewPublication Date: 2018-09-13Publisher: American Physical Society (APS)Print ISSN: 1098-0121Electronic ISSN: 1095-3795Topics: PhysicsKeywords: Dynamics, dynamical systems, lattice effectsPublished by: -
5Latest Papers from Table of Contents or Articles in PressA. Baum, Ying Li, M. Tomić, N. Lazarević, D. Jost, F. Löffler, B. Muschler, T. Böhm, J.-H. Chu, I. R. Fisher, R. Valentí, I. I. Mazin, and R. Hackl
American Physical Society (APS)
Published 2018Staff ViewPublication Date: 2018-08-08Publisher: American Physical Society (APS)Print ISSN: 1098-0121Electronic ISSN: 1095-3795Topics: PhysicsKeywords: Electronic structure and strongly correlated systemsPublished by: -
6Latest Papers from Table of Contents or Articles in PressJ. H. Chu ; H. H. Kuo ; J. G. Analytis ; I. R. Fisher
American Association for the Advancement of Science (AAAS)
Published 2012Staff ViewPublication Date: 2012-08-11Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsPublished by: -
7Latest Papers from Table of Contents or Articles in PressH. H. Kuo ; J. H. Chu ; J. C. Palmstrom ; S. A. Kivelson ; I. R. Fisher
American Association for the Advancement of Science (AAAS)
Published 2016Staff ViewPublication Date: 2016-05-21Publisher: American Association for the Advancement of Science (AAAS)Print ISSN: 0036-8075Electronic ISSN: 1095-9203Topics: BiologyChemistry and PharmacologyComputer ScienceMedicineNatural Sciences in GeneralPhysicsPublished by: -
8Latest Papers from Table of Contents or Articles in PressP. Giraldo-Gallo, P. Walmsley, B. Sangiorgio, S. C. Riggs, R. D. McDonald, L. Buchauer, B. Fauqué, Chang Liu, N. A. Spaldin, A. Kaminski, K. Behnia, and I. R. Fisher
American Physical Society (APS)
Published 2018Staff ViewPublication Date: 2018-11-14Publisher: American Physical Society (APS)Print ISSN: 0031-9007Electronic ISSN: 1079-7114Topics: PhysicsKeywords: Condensed Matter: Electronic Properties, etc.Published by: -
9Latest Papers from Table of Contents or Articles in PressP. Walmsley, C. Liu, A. D. Palczewski, P. Giraldo-Gallo, C. G. Olson, I. R. Fisher, and A. Kaminski
American Physical Society (APS)
Published 2018Staff ViewPublication Date: 2018-11-16Publisher: American Physical Society (APS)Print ISSN: 1098-0121Electronic ISSN: 1095-3795Topics: PhysicsKeywords: Superfluidity and superconductivityPublished by: -
10Articles: DFG German National LicensesStaff View
ISSN: 1569-8041Keywords: autologous transplantation ; CHOP ; diffuse large B-cell lymphoma ; IPI ; NHLSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract Background:New treatments are desperately needed to improve theresults obtained using CHOP chemotherapy for patients with diffuse large celllymphoma. In order to develop successful new strategies we need to understandwhy prior promising therapies have failed and to develop new testablehypotheses based on our current knowledge. Patients and methods:The International Non-Hodgkin's LymphomaPrognostic Factors Index has provided us with a methodology to compare theexpected prognosis of patients on different clinical trials. Many prior,apparent improvements in treatment outcome can now be attributed to theinclusion of patients with better prognoses. Results:Current areas of investigation include: l) theidentification of new active drugs for the treatment of lymphoma, 2) the useof colony stimulating factors to allow dose escalation of the activemyelotoxic drugs, 3) the use of strategies which may overcome the problem ofresistance to chemotherapy, 4) the combination of monoclonal antibodies withcombination chemotherapy and 5) ablative chemotherapy with autologousstem-cell support. Conclusions:Based on all of the available data, the NorthAmerican Lymphoma Intergroup has developed the hypothesis thathigh-intermediate and high risk patients with aggressive lymphoma who receivefull course standard induction therapy will benefit form the addition of highdose therapy and has antedated a clinical trial testing that hypothesis.Type of Medium: Electronic ResourceURL: -
11Articles: DFG German National LicensesStaff View
ISSN: 1432-0843Keywords: Key words Diffuse large-cell lymphoma ; Non-Hodgkin’s lymphoma ; CHOP ; ProMACE ; CytaBOM ; m-BACOD ; MACOP-BSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract Therapy for aggressive non-Hodgkin’s lymphomas has undergone significant evolution in the past 25 years. First-generation combination chemotherapy studies produced complete response (CR) rates of 45 – 53% together with 30 – 37% rates of long-term survival. New treatment programs aimed at increasing CR rates were then developed on the assumption that the additional patients who achieved a CR would become long-term disease-free survivors. Initial reports of single-institution pilot studies with third-generation regimens suggested CR and survival rates of 68 – 86% and 58 – 69%, respectively; however, after longer follow-up periods, survival rates decreased. Furthermore, confirmatory national phase II trials using these newer regimens produced CR rates of only 49 – 65% and survival rates of 50 – 61%. Thus, ultimate conclusions concerning the efficacy of these new regimens awaited the results of prospective randomized trials. The Southwest Oncology Group (SWOG) conducted a randomized trial comparing standard therapy, CHOP, to the third-generation chemotherapy regimens m-BACOD, ProMACE-CytaBOM, and MACOP-B. After 6 years, no difference in the response rate, progression-free survival, or overall survival has been found between CHOP and the third-generation regimens. For example, the 6-year estimates of progression-free survival are CHOP 33%, m-BACOD 36%, ProMACE-CytaBOM 34%, and MACOP-B 32% (P = 0.41). The 6-year overall survival estimates are CHOP 42%, m-BACOD 40%, ProMACE-CytaBOM 46%, and MACOP-B 41% (P = 0.89). Furthermore, we have not identified any subset of patients who survive longer on treatment with the third-generation regimens, and the cost and toxicity of the new regimens are higher. On the basis that 〈50% of these patients are cured, the best approach for any patient is an experimental one designed to improve our ability to cure the disease. Examples of this include (l) increasing the dose intensity of drugs used in standard regimens and (2) autologous bone marrow transplantation and/or peripheral stem-cell support as rescue from marrow-ablative chemotherapy. If a patient is not eligible or does not wish to participate in a clinical trial, CHOP, as inadequate as it is, remains the gold standard.Type of Medium: Electronic ResourceURL: -
12Articles: DFG German National LicensesStaff View
ISSN: 1569-8041Keywords: grey zone lymphoma ; Hodgkin's disease ; non-Hodgkin's lymphomaSource: Springer Online Journal Archives 1860-2000Topics: MedicineNotes: Abstract The inability of distinguishing difficult cases of Hodgkin's disease from non-Hodgkin's lymphoma has been a long-standing problem. Initially, the controversy centered on lymphocyte-depleted Hodgkin's disease; now with improved diagnostic techniques, most controversy centers around the anaplastic large-cell lymphomas. These problematic cases may also represent a less frequent problem, although data on this point is difficult to obtain. The future controversy may well involve the separation of T-cell rich B-cell lymphoma and Hodgkin's disease, nodular paragranuloma type. Fortunately, to date the clinical data does not support that there is a major difference in therapeutic results depending on whether these cases are treated as Hodgkin's disease or non-Hodgkin's lymphoma.Type of Medium: Electronic ResourceURL: